Skip to main content

Leif Eriksson


Department of Chemistry & Molecular
+46 31-772 34 99
Visiting address
Medicinaregatan 9c, Lundberg Lab,
41390 Göteborg
Room number
Postal address
Box 462
40530 Göteborg

About Leif Eriksson

Contact information: Lundberg Lab, Medicinareg. 9c, 40530 Göteborg; office 1405.


Theoretical biophysical chemistry in form of computer based modeling of various biochemical processes and systems. Our focus has for a long time related to DNA damage processes, cancer and drug design; often linked to radical and photochemistry. In recent years, we have explored increasingly larger systems, including diffusion across biological membranes, drug loaded liposomes, derivation of protein structures and studies of their mechanisms, modeling of protein-protein complexes, and development of new inhibitors in cancer treatment and as antibiotics.

We utilize a wide range of methods in our research, from DFT and QM/MM to molecular dynamics simulations and bioinformatic tools such as VHTS/docking and homology modeling.

ResearcherID: D-1226-2012 ORCID: 0000-0001-5654-3109

Current research group: 1 researcher (Dr Anna Reymer), 4 Postdocs (Dr Antonio Carlesso, Dr Jalil Mahdizadeh, Dr Kevin Moreau, Dr Melissa Thomas), 2 PhD students (Fredrik Lannestam Holmelin, Johanna Hörberg), and several Master students, visiting researchers and PhD students.


Mainly on the following courses: General chemistry (KEM011) Analytical pharmaceutical chemistry (KER210) General pharmaceutical chemistry (KER220) Basic Molecular Modeling (KEM552)


Vice head of department for research. Reviewer in SNAC (Swedish National Allocations Comittee for Supercomputing).

Participates in H2020 MSCA-RISE projects VIDEC and INSPIRED. Member of UGOT CARe (Center for Antibiotics Resistance Research). Editorial Board Member in Scientific Reports (Nature Publ Grp)


Leif Eriksson studied Chemistry at Stockholm university and University of Sussex 1985-1988. He received his PhD in Quantum chemistry at Uppsala Universitet (1992), followed by a postdoctoral fellowship from the Swedish research council VR (then 'NFR') to go to Dalhousie University, Canada, 92/93. He most recently comes from NUI Galway, Ireland, and holds the current professorship in physical chemistry at GU since 2011. He was awarded the 2017 Pedagogic price from the Science section of the Göta Student Union at University of Gothenburg.

Eriksson has published >285 peer reviewed research papers and some 20 review papers and book chapters, in the field of theoretical/computational (bio)chemistry. He holds the patents of new pharmaceuticals targeting skin cancer, glioblastoma, and Vitamin A degradation, and is part owner of spin-out companies C26 Bioscience, and Cell Stress Discoveries. He is currently involved in the development of several new drugs, of which the first are in the patenting stage.